Arctoris combines its unique automation platform, Ulysses, with advanced computational approaches and a world-class team of seasoned drug hunters to guide and rapidly progress its wholly owned and partnered drug discovery programs in oncology and neurology.

With millions suffering from chronic illnesses, the world continues to be in desperate need of new and better therapies to improve and extend lives. This is why we are here: we combine a world-class team with a unique integrated technology architecture to drive our mission to revolutionize drug discovery and accelerate the development of new medicines. Better data today will lead to better drugs tomorrow.